Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_assertion type Assertion NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_head.
- NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_assertion description "[Twenty-seven (24 male and 3 female, mean age 34+/-8 years) renal transplant recipients with erythrocytosis were treated either with E (15 patients) (10 mg/day) or L (12 patients) (50 mg/day) for 8 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_provenance.
- NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_assertion evidence source_evidence_literature NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_provenance.
- NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_assertion SIO_000772 11502994 NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_provenance.
- NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_assertion wasDerivedFrom befree-20140225 NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_provenance.
- NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_assertion wasGeneratedBy ECO_0000203 NP246164.RA1hDZ5la6Y1yBzoT5uc07-WC1f68BhOq0e0IJJP_zsZk130_provenance.